secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001099800-25-000046
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FTC moves to block Edwards' proposed JenaValve acquisition; Edwards raises FY2025 adjusted EPS guidance to $2.45-$2.55
--------------------------------------------------------------------------------

- FTC moved to block Edwards' proposed acquisition of JenaValve Technology; Edwards disagrees and will continue pursuing regulatory approval.
- Edwards estimates a final determination on the acquisition by end of Q1 2026.
- Full-year 2025 adjusted EPS guidance raised to high-end of $2.45-$2.55 (from $2.40-$2.50); revenue guidance unchanged.
- Minimal impact to Q3 2025 adjusted EPS guidance from FTC action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980025000046/0001099800-25-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980025000046/ew-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001099800-25-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer